KNOXVILLE, Tenn. (AP) — KNOXVILLE, Tenn. (AP) — Provectus Biopharmaceuticals Inc. (PVCT) on Tuesday reported a loss of $776,000 in its third quarter.

On a per-share basis, the Knoxville, Tennessee-based company said it had a loss of less than 1 cent.

The biopharmaceutical posted revenue of $69,700 in the period. Its adjusted revenue was $70,000.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PVCT at https://www.zacks.com/ap/PVCT

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News